SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-042367
Filing Date
2023-08-14
Accepted
2023-08-14 16:02:49
Documents
111
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q gls-20230630.htm   iXBRL 10-Q 4152795
2 EX-31.1 gls-ex31_1.htm EX-31.1 19429
3 EX-31.2 gls-ex31_2.htm EX-31.2 22328
4 EX-32.1 gls-ex32_1.htm EX-32.1 13913
5 EX-32.2 gls-ex32_2.htm EX-32.2 13907
  Complete submission text file 0000950170-23-042367.txt   16260648

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gls-20230630_lab.xml EX-101.LAB 822831
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gls-20230630.xsd EX-101.SCH 127137
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gls-20230630_cal.xml EX-101.CAL 79244
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gls-20230630_def.xml EX-101.DEF 507304
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gls-20230630_pre.xml EX-101.PRE 694432
105 EXTRACTED XBRL INSTANCE DOCUMENT gls-20230630_htm.xml XML 3327991
Mailing Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116 857-327-7737
GELESIS HOLDINGS, INC. (Filer) CIK: 0001805087 (see all company filings)

IRS No.: 844730610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39362 | Film No.: 231169641
SIC: 2834 Pharmaceutical Preparations